Bristol-Myers could spend $2.2B in deal with Dutch biotech (Update)
Bristol-Myers Squibb, one of the world's largest drugmakers, will team up with a Dutch biotechnology company whose first approved drug could cost more than $1 million.
Apr 6, 2015
0
6